Urotoxicity of enocitabine (BH-AC) and aclarubicin (ACM) in pediatric patients with hematological malignancies

F. Fujiwara, T. Yoshihara, S. Ikushima, N. Esumi, S. Todo, Y. Morioka, S. Imashuku, S. Okano, T. Hashida, T. Ishii

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Urotoxicity of enocitabine (BH-AC) and aclarubicin (ACM) in pediatric patients with hematological malignancies'. Together they form a unique fingerprint.